NOxBOXi Delivery System Correction Issued After Reports of Nitric Oxide Dose Fluctuations
The FDA issued a safety alert after users reported nitric oxide dose fluctuations, potentially leading to hypoxemia or increased pulmonary artery pressure.
The FDA issued a safety alert after users reported nitric oxide dose fluctuations, potentially leading to hypoxemia or increased pulmonary artery pressure.
The $200K award supports expansion of the FDA-cleared wireless platform for blood pressure and hemodynamic monitoring.
Clario's SpiroSphere platform received U.S. FDA clearance for its wireless COR-12 ECG device, consolidating spirometry and ECG data collection.
The FDA issued a safety alert after users reported nitric oxide dose fluctuations, potentially leading to hypoxemia or increased pulmonary artery pressure.
A study evaluated the ability of Masimo SedLine brain function monitoring to assess sedation levels during a drug-induced procedure.
Read MoreGE HealthCare announced it has received 510(k) clearance from the FDA for its Portrait Mobile wireless and wearable monitoring solution.
Read MoreA new report details how Sky Labs’ cuffless blood pressure measurement algorithm used in its CART-I BP device enables improved hypertension management and early prediction of cardiovascular events.
Read MoreRoyal Philips and Masimo announce U.S. FDA clearance allowing the activation of SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO₂ measurements in Philips patient monitors: IntelliVue MX750 and MX850.
Read MoreHoneywell developed a real-time health monitoring system, which captures and records patients’ vital signs both in the hospital and remotely.
Read MoreIcentia has received U.S. FDA clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that uses a wireless, single-use recorder.
Read More
Royal Philips and Northwell Health have entered into a seven-year agreement to help the health system standardize patient monitoring.